2007
DOI: 10.1172/jci32390
|View full text |Cite
|
Sign up to set email alerts
|

Overexpression of sPRDM16 coupled with loss of p53 induces myeloid leukemias in mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

5
76
0

Year Published

2008
2008
2012
2012

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 55 publications
(81 citation statements)
references
References 45 publications
5
76
0
Order By: Relevance
“…The CALGB (Cancer and Leukemia Group B) study showed significantly prolonged median time to progression to leukaemia and/or death, whereas AZA 001 trial showed a prolonged overall survival (OS) compared with conventional care regimens. [1][2][3] Recently, it has been reported that abnormal karyotype independently predicted lower response rates to azacitidine and that intermediate-and poor-risk cytogenetics independently predicted poorer OS. 4 Inversion of chromosome 3 (inv(3) (q21;q26)), with EVI-1 (ecotropic viral integration site 1) transcriptional activation, is relatively common in myeloid malignancies and was reported in acute myeloid leukaemia, chronic myeloid leukaemia in blast crisis and myelodysplastic syndromes (MDS).…”
Section: Conflict Of Interestmentioning
confidence: 99%
See 1 more Smart Citation
“…The CALGB (Cancer and Leukemia Group B) study showed significantly prolonged median time to progression to leukaemia and/or death, whereas AZA 001 trial showed a prolonged overall survival (OS) compared with conventional care regimens. [1][2][3] Recently, it has been reported that abnormal karyotype independently predicted lower response rates to azacitidine and that intermediate-and poor-risk cytogenetics independently predicted poorer OS. 4 Inversion of chromosome 3 (inv(3) (q21;q26)), with EVI-1 (ecotropic viral integration site 1) transcriptional activation, is relatively common in myeloid malignancies and was reported in acute myeloid leukaemia, chronic myeloid leukaemia in blast crisis and myelodysplastic syndromes (MDS).…”
Section: Conflict Of Interestmentioning
confidence: 99%
“…1 Transgenic expression of the generated aberrant transcripts and corresponding fusion proteins often induces leukemia in mice, suggesting a role in disease onset. 2 The MYB gene, on human chromosome 6, corresponds to a 75-kDa transcription factor exerting a physiological function in the hematopoietic system (reviewed in Ramsay and Gonda 3 ). GATA1, a nuclear protein with an essential role in hematopoiesis, is coded by a gene located on the human X chromosome (reviewed in Shimizu et al 4 ).…”
mentioning
confidence: 99%
“…More than half of these immortalized lines had activating proviral insertional mutations in two well-known human myeloid leukemia oncogenes important for hematopoietic stem cell self-renewal, Evi1 and Prdm16 (35,36). These immortalized immature myeloid cells were not tumorigenic in transplanted hosts, however, probably because the retrovirus used in these experiments was replication-defective and could not induce the additional rounds of insertional mutations required for tumor development in transplanted mice.…”
Section: Discussionmentioning
confidence: 96%
“…In addition, the expression patterns implied that the PRDM16 gene has additional functions besides its roles on brown fat tissues. For instance, the up-regulation of PRDM16 could initiate a leukemogenic cascade (Shing et al, 2007;Modlich et al, 2008), and the copy number of PRDM16 molecules of patients with osteosarcoma was higher than that of the normal (Man et al, 2004).…”
mentioning
confidence: 99%